Bioinformatics Strategies for Translating Genome-Wide Expression Analyses into Clinically Useful Cancer Markers
dc.contributor.author | Rhodes, Daniel R. | en_US |
dc.contributor.author | Chinnaiyan, Arul M. | en_US |
dc.date.accessioned | 2010-06-01T20:18:17Z | |
dc.date.available | 2010-06-01T20:18:17Z | |
dc.date.issued | 2004-05 | en_US |
dc.identifier.citation | RHODES, DANIEL R.; CHINNAIYAN, ARUL M. (2004). "Bioinformatics Strategies for Translating Genome-Wide Expression Analyses into Clinically Useful Cancer Markers." Annals of the New York Academy of Sciences 1020(1 The Applications of Bioinformatics in Cancer Detection ): 32-40. <http://hdl.handle.net/2027.42/73423> | en_US |
dc.identifier.issn | 0077-8923 | en_US |
dc.identifier.issn | 1749-6632 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73423 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=15208181&dopt=citation | en_US |
dc.description.abstract | The DNA microarray has revolutionized cancer research. Now, scientists can obtain a genome-wide perspective of cancer gene expression. One potential application of this technology is the discovery of novel cancer biomarkers for more accurate diagnosis and prognosis, and potentially for the earlier detection of disease or the monitoring of treatment effectiveness. Because microarray experiments generate a tremendous amount of data and because the number of laboratories generating microarray data is rapidly growing, new bioinformatics strategies that promote the maximum utilization of such data are necessary. Here, we describe a method to validate multiple microarray data sets, a Web-based cancer microarray database for biomarker discovery, and methods for integrating gene ontology annotations with microarray data to improve candidate biomarker selection. | en_US |
dc.format.extent | 2667819 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 2004 New York Academy of Sciences | en_US |
dc.subject.other | Cancer | en_US |
dc.subject.other | Biomarkers | en_US |
dc.subject.other | Bioinformatics | en_US |
dc.subject.other | Meta-analysis | en_US |
dc.subject.other | Microarray | en_US |
dc.title | Bioinformatics Strategies for Translating Genome-Wide Expression Analyses into Clinically Useful Cancer Markers | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Science (General) | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA | en_US |
dc.contributor.affiliationum | Department of Urology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA | en_US |
dc.contributor.affiliationum | Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA | en_US |
dc.identifier.pmid | 15208181 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73423/1/annals.1310.005.pdf | |
dc.identifier.doi | 10.1196/annals.1310.005 | en_US |
dc.identifier.source | Annals of the New York Academy of Sciences | en_US |
dc.identifier.citedreference | Rubin, M.A. et al. 2002. Alpha-methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA 287: 1662 – 1670. | en_US |
dc.identifier.citedreference | Dhanasekaran, S.M. et al. 2001. Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822 – 826. | en_US |
dc.identifier.citedreference | Luo, J. et al. 2001. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling. Cancer Res. 61: 4683 – 4688. | en_US |
dc.identifier.citedreference | Magee, J.A. et al. 2001. Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res. 61: 5692 – 5696. | en_US |
dc.identifier.citedreference | Welsh, J.B. et al. 2001. Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc. Natl. Acad. Sci. USA 98: 1176 – 1181. | en_US |
dc.identifier.citedreference | Rhodes, D.R. et al. 2002. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 62: 4427 – 4433. | en_US |
dc.identifier.citedreference | Varambally, S. et al. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624 – 629. | en_US |
dc.identifier.citedreference | Rhodes, D.R. et al. 2003. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J. Natl. Cancer Inst. 95: 661 – 668. | en_US |
dc.identifier.citedreference | Mok, S.C. et al. 2001. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J. Natl. Cancer Inst. 93: 1458 – 1464. | en_US |
dc.identifier.citedreference | Ye, Q.H. et al. 2003. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat. Med. 9: 416 – 423. | en_US |
dc.identifier.citedreference | Brazma, A. et al. 2001. Minimum information about a microarray experiment (MIAME)—toward standards for microarray data. Nat. Genet. 29: 365 – 371. | en_US |
dc.identifier.citedreference | Edgar, R., M. Domrachev & A.E. Lash. 2002. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207 – 210. | en_US |
dc.identifier.citedreference | Brazma, A. et al. 2003. Array Express—a public repository for microarray gene expression data at the EBI. Nucleic Acids Res. 31: 68 – 71. | en_US |
dc.identifier.citedreference | Welsh, J.B. et al. 2001. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61: 5974 – 5978. | en_US |
dc.identifier.citedreference | 15 Rhodes, D.R. et al. 2004. Large-scale meta-analysis of cancer microarray data identifies common gene expression profiles of neoplastic transformation and progression. Under review. | en_US |
dc.identifier.citedreference | Rhodes, D.R. et al. 2004. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1 – 6. | en_US |
dc.identifier.citedreference | Ashburner, M. et al. 2000. Gene ontology: tool for the unification of biology—The Gene Ontology Consortium. Nat. Genet. 25: 25 – 29. | en_US |
dc.identifier.citedreference | Welsh, J.B. et al. 2003. Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc. Natl. Acad. Sci. USA 100: 3410 – 3415. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.